Abstract
The emergence of cellular immunology in the second half of the 20th century triggered the interest of scientists and clinicians to explore the potential role of immune-mechanisms in degenerative chronic diseases, among others in athero- arteriosclerosis. These experiments were preceeded and encouraged by the important work of Klemperer, who coined the term collagenoses implying autoantibodies to collagen in such chronic diseases as disseminated lupus erythematosis and related chronic affections of connective tissues (Gardner 1965 for review). Several authors obtained reproducible vascular lesions similar to those observed in humans by immuni z ing rabbits with arterial wall homogenates. Using a fractional extraction procedure we could show that the major antigen responsible for this experimental immune-atherosclerosis was elastin, considered previously as nonantigenic. The more hydrosoluble macromolecular fractions of the vascular wall, although strongly antigenic, as judged from the production of precipitating antibodies, did not produce the same lesions with the same regularity and severity. Immuni z ation of rabbits with highly purified elastin induced only a modest increase of circulating antibodies, but did produce arteriosclerotic plaques without any increase of dietary lipid administration. These results were completed and reinterpreted after the identification of the elastin-laminin receptor, activated by circulating elastin peptides by triggering a release of proteolytic enzymes and free radicals. The functional profile as well as the transmission pathway of this receptor, present on vascular cells and also on circulating white blood cells (WBC) was shown to change with age, loosing its physiologically relevant regulatory functions and preserving only its harmful effects. Circulating elastin peptides acting on the elastin receptor (ER) can induce vascular damage by upregulation of proteolytic (elastolytic) activity and reactive oxygen species (ROS) production. These reactions form a vicious circle with autoamplifying feedback mechanisms and age-dependent increase of the harmful effects on the vascular wall. A large number of human blood samples were tested for antielastin antibodies and also for elastin peptides. All blood samples contained both of these markers of the (auto)immune atherogenetic process involving the activation of the elastin-receptor, its uncoupling which results in the progressive increase of the degradative processes leading to the age-dependent amplification of the athero- arteriosclerosis. Elastin peptides were also shown to induce oxydation of LDL. This experimental model is an example of the delicate interplay of immune-triggered reactions with cell-signaling events during the development of athero- arteriosclerosis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Antonicelli F, Bellon G, Debelle L, Hornebeck W. (2007) Elastin-elastases and inflamm-aging Cur Topics Dev Biol 79:99–155
Archilla-Marcos M, Robert L (1993) Control of the biosynthesis and excretion of the elastase-type protease of human skin fibroblasts by the elastin receptor Clin Physiol Biochem 10:86–91
Beaumont J-L, Jacotot B, Vilain C, Beaumont V (1965) Presence of an anti-beta-lipoprotein autoantibody in a myeloma seum. C R Acad Sci 260:5960–5962
Beaumont J-L (1965) Hyperlipidemia caused by anti-beta-lipoprotein antibodies. A new pathological entity C R Acad Sci 261:4563–4566
Beaumont V, Beaumont J-L (1968) Experimental hyperlipemia induced by immunization in the rabbit Path Biol 16:870–876
Beaumont J-L (1969) Gamma globulins and hyperlipemia. Hyperlipemia caused by autoantibodies. Ann Biol Clin 27:611–635
Beaumont J-L (1970) Auto-immune hyperlipidemia. An atherogenic metabolic disease of immune origin. Rev Eur Etud Clin Biol 15:1037–1041
Beaumont J-L, Lemort N (1974) Anti-heparin immunoglobulins, a factor of thrombosis, hyperlipidemia and atherosclerosis. Path Biol 22:67–76
Bieth J (1978) Elastases: structure, function and pathological role. In:Robert L (ed) Frontiers in matrix biology, vol 6. Karger, Basel, pp 1–82
Bihari-Varga M, Gero S (1966) Role of intimal mucoid substances in the pathogenesis of atherosclerosis. Investigations on the components of the mucopolysaccharide-beta-lipoprotein complex formation in vitro. Acta Physiol Acad Sci Hung 29:273–281
Bihari-Varga M, Keller L, Landi A, Robert L (1884) Elastase-type activity, elastase inhibitory capacity, lipids and lipoproteins in the sera of patients with ischemic vascular disease. Atherosclerosis 50:273–281
Bihari-Varga M, Kadar A, Jacob M-P, Robert L (1986) Physicochemical and ultrastructural properties of cholesterol esters bound to elastin Connect Tissue Res 15:43–55
Bing DK, Weygand JGM, Stavitsky AB (1967) Hemagglutination with aldehyde-fixed erythrocytes for assay of antigens and antibodies. Proc Soc Exptl Biol Med 124:1168
Bizbiz L, Bonithon-Kopp C, Ducimetière P, Berr C, Alperovitch A, Robert L (1996) Relation of serum elastase activity to ultrasonographically assessed carotid artery wall lesions and cardiovascular risk factors. The EVA study. Atherosclerosis 120:47–55
Bizbiz L, Alperovitch A, Robert L, and the EVA group (1997) Aging of the vascular wall: serum concentration of elastin peptides and elastase inhibitors in relation with cardiovascular risk factor. The EVA study. Atherosclerosis 131:73–78
Bourdillon M-C, Soleilhac J-M, Crouzet B, Robert L, Hornebeck W (1984) Influence of lipoproteins on elastase-type activity of arterial smooth muscle cells in culture. Cell Biol Internat Rep 8:415–421
Bürger M (1947) Altern und Krankheit. Georg Thieme, Leipzig
Burstein M, Samaille J (1959) Nouvelle méthode de séparation et de dosage des lipoprotéines de faible densité. Ann Biol Clin 17:23
Buxtorf J-C, Lorenzelli-Edouard L, Beaumont J-L (1981) Immunoglobulins and hyperlipoproteinemias. Biomedicine 35:90–93
Claire M, Jacotot B, Robert L (1976) Characterisation of lipids associated with macromolecules of the intercellular matrix of human aorta. Connect Tissue Res 4:61–71
Comper WD (ed) (1996) Extracellular Matrix, vol. I–II. Harwood Academic Publishers, Australia
Faury G, Ristori MT, Verdetti J, Jacob M-P, Robert L (1995) Effect of elastin peptides on vascular tone. J Vasc Res 32:112–119
Faury G, Chabaud A, Ristori MT, Robert L, Verdetti J (1997) Effect of age on the vasodilatatory action of elastin peptides. Mech Aging Dev 95:31–42
Faury G, Usson Y, Robert-Nicoud M, Robert L, Verdetti J (1998a) Nuclear and cytoplasmic free calcium level changes induced by elastin peptides in human endothelial cells. Proc Natl Acad Sci 95:2967–2972
Faury G, Garnier S, Weiss AS, Wallach J, Fülöp T Jr, Jacob M-P, Mecham RP, Robert L, Verdetti J (1998b) Action of tropoelastin and synthetic elastin sequences on vascular tone and on free calcium level in human vascular endothelial cells. Circ Res 82:328–336
Fülöp T Jr, Jacob M-P, Robert L (1989a) Determination of anti-elastin antibodies in normal and atherosclerotic human sera by ELISA. J Clin Lab Immunol 30:69–74
Fülöp T Jr, Jacob M-P, Robert L (1989b) Biological effects of elastin peptides. In: Robert L, Hornebck W (eds) Elastin and elastases, vol I. CRC Press, Boca Raton, pp 201–210
Fülöp T Jr, Varga Zs, Csongor J, Jacob M-P, Robert L, Leovey A, Foris G (1990a) Altered phosphatidylinositol breakdown in polymorphonuclear leukocytes with aging. In:Goldstein AL (ed) Biomedical advances in aging. Plenum Publishing, New York
Fülöp T Jr, Wei SM, Robert L, Jacob M-P (1990b) Determination of elastin peptides in normal and atherosclerotic human sera by ELISA. Clin Physiol Biochem 8:273–282
Fülöp T Jr, Barabas G, Varga Zs, Csongor J, Hauck M, Szücs S, Seres I, Mohacsi A, Kekessy D, Despont J-P Robert L, Penyige A (1992) Transmembrane signaling changes with age. Ann New York Acad Sci 673:165–171
Fülöp T Jr, Douziech N, Jacob M-P, Hauck M, Wallach J, Robert L (2001) Age-related alterations in the signal transduction pathways of the elastin-laminin receptor. Path Biol 49:339–348
Fülöp T Jr, Larbi A, Fortun A, Robert L, Khalil A (2005) Elastin peptides induced oxidation of LDL by phagocytic cells. Path Biol 53:416–423
Gardner DL (1965) Pathology of the connective tissue diseases Edward Arnold Publishers, London
Gero S, Gergely J, Jakab L, Székely J, Virag S, Farkas K, Czuppon A (1959) Inhibition of cholesterol atherosclerosis by immunisation with beta-lipoprotein. Lancet 7088:6–7
Gero S, Gergely J, Dévényi T, Jakab L, Székely J, Virag S (1960) Role of mucoid substances of the aorta in the deposition of lipids. Nature 187:152–153
Gero S (1967) Some data on the influence of cholesterol atherosclerosis by immunological means. Rev Atheroscler (Paris) 9(Suppl 1):194–198
Groult V, Hornebeck W, Robert L, Pouchelet M, Jacob M-P (1998) Interactions of elastic fibers with fibroblasts – A time-lapse cinematographic study. Path Biol 46:507–516
Hornebeck W, Partridge M (1975a) Conformational changes in fibrous elastin due to calcium ions. Eur J Biochem 51:73–78
Hornebeck W, Derouette J-C, Robert L (1974b) Isolation, purification and properties of aortic elastase. FEBS Lett 58:66–70
Hornebeck W, Potazman JP, De Cremoux H, Bellon G, Robert L (1983) Elastase-type activity of human serum., Clin Physiol Biochem 1:285–292
Hornebeck W, Tixier J-M, Robert L (1986) Inducible adhesion of mesenchymal cells to elastic fibers: elastonectin. Proc Natl Acad Sci 83:5517–5520
Jacob M-P, Brechemier D, Robert L, Hornebeck W (1982) Variation of elastase-type protease activity and elastin biosynthesis in rabbit aorta induced by cholesterol diet. Artery 10:310–316
Jacob M-P, Hornebeck W, Robert L (1983) Studies on the interaction of cholesterol with soluble and insoluble elastins. Int J Biol Macromol 5:275–278
Jacob M-P, Hornebeck W, Lafuma C, Bernaudin JF, Robert L, Godeau G (1984) Ultrastructural and biochemical modifications of rabbit arteries induced by immunisation with soluble elastin peptides. Exp Mol Pathol 41:171–190
Jacob M-P, Fülöp T Jr, Foris G, Robert L (1987a) Effect of elastin peptides on ion fluxes in mononuclear cells, fibroblasts and smooth muscle cells. Proc Natl Acad Sci 84:995–999
Jacob M-P, Moura AM, Tixier J-M, Lafuma C, Robert AM, Robert L, Worcel M (1987b) Prevention by calcitonin of the pathological modifications of the rabbit arterial wall induced by immunisation with elastin peptides: effect on vascular smooth muscle permeability. Exper Mol Pathol 46:345–356
Jacotot B, Beaumont J-L, Monnier G, Szigeti M, Robert B, Robert L (1973) Role of elastic tissue in cholesterol deposition in the arterial wall. Nutr Metabol 15:46–58
Joseph JA, Roth GS (1990) Loss of agonist-receptor efficacy in senescence: possible decrements in second messenger function and calcium mobilisation. In: Bergener M, Ermini M, Stähelin HB (eds) Challenges in aging. Acadamic Press, New York, pp 167–184
Labat-Robert J, Robert L (2007) The effect of cell-matrix interactions and aging on the malignant process. In: Advances in cancer research, vol. 98. Elsevier, Amsterdam, pp 221–259
Lansing AI (ed) (1959) The arterial wall. The Williams & Wilkins Co, Baltimore
Lorenzelli-Edouard L, Marie F, Beaumont J-L (1980) Antilipoprotein autoimmune hyperlipidemia. The Ig-Lp test. Biomedicine 33:160–163
Minick CR, Murphy GE, Campbell WG Jr (1966) Experimental induction of athero- arteriosclerosis by the synergy of allergic injury to arteries and lipid rich diet. J Exp Med 124:635
Olsson AG (ed) (1987) Atherosclerosis. Biology and clinical science. Churchill Livingstone, Edinburgh
Perdomo JJ, Gounon P, Schaeverbeke M, Schaeverbeke J, Groult V, Jacob MP, Robert L (1994) Interaction between cells and elastin fibers: an ultrastructural and immunocytochemical study. J Cell Physiol 158:451–458
Péterszegi G, Mandet C, Texier S, Robert L, Bruneval P (1997a) Lymphocytes in human atherosclerotic plaques exhibit the elastin-laminin receptor: potential role in atherogenesis. Atherosclerosis 135:103–107
Péterszegi G, Texier S, Robert AM, Moulias R, Robert L (1997b) Increased elastase and cathepsin G activity in activated lymphocytes from aged patients. Role of denutrition and dementia. Arch Gerontol Geriatr 25:285–298
Péterszegi G, Texier S, Robert L (1997c) Human helper and memory lymphocytes exhibit an inducible elastin-laminin receptor. Int Arch Allergy Immunol 114:218–223
Péterszegi G, Texier S, Robert L (1999) Cell death by overload of the elastin-laminin receptor on human activated lymphocytes : protection by lactose and melibiose. Eur J Clin Invest 29:166–172
Renais J, Groult N, Scebat L, Lenegre J (1968) Pouvoir antigénique et pathogène du tissu artériel. In: Le rôle de la paroi artérielle dans l’atherogénèse. Colloque International CNRS, Paris
Robert AM, Grosgogeat Y, Reverdy V, Robert B, Robert L (1971) Lésions artérielles produites chez le lapin par immunisation avec l’élastine et les glycoprotéines de structure de l’aorte. Études biochimiques et morphologiques. Atherosclerosis 13:427–449
Robert B, Szigeti M, Derouette J-C, Robert L, Bouissou H, Fabre M-T (1971) Studies on the nature of the microfibrillar component of elastic fibers. Eur J Biochem 21:507–516
Robert B, Hornebeck W, Robert L (1974a) Cinétique hétérogène de l’interaction élastine-élastase. Biochimie 56:239–244
Robert B, Derouette J-C, Robert L (1974b) Mise en évidence de protéases à activité élastolytique dans les extraits d’aortes humaines et animales. C R Acad Sci Paris 278:3251–3254
Robert B, Robert L, Robert AM (1974c), Elastrine, élastase et artériosclérose. Path Biol 22:661–669
Robert B, Robert L (1975) Aortic elastase, its role in the degradation of arterial elastin. In: Peeters H (ed) Protids of biological fluids. Pergamon Press, pp 413–418
Robert L, Poullain N (1963) Étude sur la structure de l’élastine et le mode d’action des élastases. I. Nouvelle méthode de préparation des dérivés solubles de l’élastine. Bull Soc Chim Biol 45:1317–1326
Robert L, Parlebas I (1965) Biosynthèes in vitro des glycoprotéines de la cornée. Bull Soc Chim Biol 47:1853–1866
Robert L, Stein F, Pezess MP, Poullain N (1967), Propriétés immunochimiques de l’élastine. Leur importance dans l’atherosclerose. Arch Maladies du Coeur 60(Suppl. 1):233–241
Robert L, Robert AM, Moczar M, Moczar E (1968) Constituants macromoléculaires de la paroi artérielle. Antigénicité et rôle dans l’atherosclérose. In: Le rôle de la paroi artérielle dans l’atherosclérose. Colloque CNRS, pp 395–424, Paris
Robert L, Robert B, Medema J, Houtman JPW (1970a) Surface areas of elastin samples determined by krypton-85 adsorption. Biochim Biophys Acta 214:235–237
Robert L, Robert B, Robert AM (1970b) Molecular biology of elastin as related to aging and atherosclerosis. Exptl Gerontol 5:339–356
Robert L, Robert B, Houtman JPW, Stack MV (1971) Flow calorimetry of the sorption of butanol to elastin preparations and comparison with surface areas determined by Krypton-85 adsorption., Biochim Biophys Acta 251:370–375
Robert L, Robert B (1973) Immunology and aging. Gerontologia 19:330–335
Robert L, Jacob M-P, Szemenyei K, Robert AM (1984a) Pharmacological properties of elastin peptides, their action on serum and aorta lipids and on the atherosclerotic process. In:Carlson LA, Olsson AG (eds) Treatment of hyperlipoproteinemia, Raven Press, New York, pp 185–188
Robert L, Chaudière J, Jacotot B (1984b) Interaction between lipids and the intercellular matrix of the arterial wall: its role in the evolution of atherosclerotic lesions. In: Malinow R, Blaton VH (eds) Regression of atherosclerotic lesions. Plenum Publishing Corporation, pp 145–173
Robert L, Jacob M-P, Frances C, Godeau G, Hornebeck W (1984c) Interaction between elastin and elastases and its role in the aging of the arterial wall, skin and other connective tissues. A review. Mech Aging Dev 28:155–166
Robert L, Moczar M, Moczar E (eds) (1985) Methods of connective tissue research. Frontiers in matrix biology, vol 10. Karger, Basel
Robert L, Labat-Robert J, Hornebeck W (1986) Aging and atherosclerosis. Atherosclerosis Rev 14:143–170, Raven Press, New York
Robert L, Jacob M-P, Fülöp T Jr, Timar J, Hornebeck W (1989) Elastonectin and the elastin receptor. Path Biol 37:736–741
Robert L (1996) Aging of the vascular wall and atherogenesis: role of the elastin-laminin receptor. Atherosclerosis 123:169–179
Robert L (1998) Mechanisms of aging of the extracellular matrix. Role of the elastin-laminin receptor. Novartis Price Lecture. Gerontology 44:307–317
Robert L (1999a) Aging of the vascular wall and atherosclerosis. Exper Gerontol 34:491–501
Robert L (1999b) Interaction between cells and elastin, the elastin receptor. Connect Tissue Res 40:75–82
Robert L, Labat-Robert J (2000) Aging of connective tissues, from genetic to epigenetic mechanisms. Biogerontology 1:123–131
Roth GS (1979) Hormone receptor changes during adulthood and senescence: significance for aging research. Federation Proc 38:1910–1914
Rouis M, Nigon F, Lafuma C, Hornebeck W, Chapman J (1990) Expression of elastase activity by human monocyte-macrophages is modulated by cellular cholesterol content, inflammatory mediators and phorbol myristate acetate. Arteriosclerosis 10:246–255
Scebat L, Renais J, Iris L, Groult N, Lenegre J (1966) Lésions artérielles produites chez le lapin par des injections de broyat d’aorte homologue et hétérologue. Arch Mal Coeur 59 (suppl.n°1) Rev Athér Arter Périph, pp. 56–72
Scebat L, Renais J, Groult N, Iris L, Lenegre J (1967), Arterial lesions produced in rabbits by injections of pulverized rat aorta. Preliminary study. Rev Atheroscler (Paris) 9:249–262
Stein F, Pezess M-P, Robert L, Poullain N (1965) Anti-elastin antibodies in normal and pathological human sera. Nature 207:312–313
Szigeti I, Ormos J, Jako J, Toszegi A (1960) The atherogenic effect of immunisation with homologous complex great vessel wall in rabbit. Acta Allergologica (suppl. VII):374–387
Szigeti I, Jako I, Doman J (1968) Study of the antigenic and immunopathological effects of structural proteins of the mammalian arterial wall and their role in the pathogenesis of atherosclerosis. In: colloque CNRS N° 169: Le rôle de la paroi artérielle dans l’athérogénèse, pp 387–394 , Paris
Szigeti M, Monnier G, Jacotot B, L. Robert (1972) Distribution of ingested 14C-cholesterol in the macromolecular fractions of rat connective tissue. Connect Tissue Res 1:145–152
Timar J, Diczhazi Cs, Ladanyi A, Raso E, Hornebeck W, Robert L, Lapis K (1995) Interaction of tumor cells with elastin and the metastatic phenotype. In: The molecular biology and pathology of elastic tissues. John Wiley & Sons, Chichester pp 321–333
Trentham DE (1984) Immunity to type II collagen in rheumatoid arthritis: a current appraisal. Proc Soc Exp Biol Med 176:85–104
Urry DW (1980) Sequential polypeptides of elastin. Structural properties and molecular pathologies. Front Matrix Biology. In: Robert AM, Robert L (eds) Biology and pathology of elastic tissues, vol 8. Karger, Basel, pp 78–103
Varga Z, Kovacs EM, Paragh G, Jacob M-P, Robert L, Fülöp T Jr (1988) Effect of elastin peptides and N-Formyl-methionyl-Leucyl-Phenylalanine on cytosolic free calcium in polymorphonuclear leucocytes of healthy middle-aged and elderly subjects. Clin Biochem 21:127–130
Varga Z, Jacob M-P, Robert L, Fülöp T Jr (1989) Identification and signal transduction mechanism of elastine peptide receptor in human leucocytes. FEBS Lett 258:5–8
Varga Z, Jacob M-P, Robert L, Csongor J, Fülöp T Jr (1997) Age-dependent changes of k-elastin stimulated effector functions of human phagocytic cells: relevance for atherogenesis. Exp Gerontol 32:653–662
Wei S.M, Erdei J, Fülöp T Jr, Robert L, Jacob M-P (1993) Elastine peptide concentration in human serum : variation with antibodies and elastin peptides used for the enzyme-linked immunosorbent assay. J Immunol Methods 164:175–187
White FN, Grollman A (1964) Experimental periarteritis nodosa in the rat Arch Pathol 78:31
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer Science+Business Media B.V.
About this chapter
Cite this chapter
Robert, L., Robert, A.M. (2009). Immuno-Inflammatory Athero-Arteriosclerosis Induced by Elastin Peptides. Effect of Age. In: Fulop, T., Franceschi, C., Hirokawa, K., Pawelec, G. (eds) Handbook on Immunosenescence. Springer, Dordrecht. https://doi.org/10.1007/978-1-4020-9063-9_54
Download citation
DOI: https://doi.org/10.1007/978-1-4020-9063-9_54
Publisher Name: Springer, Dordrecht
Print ISBN: 978-1-4020-9062-2
Online ISBN: 978-1-4020-9063-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)